Regulation

How Can Healthcare Optimize IT Spending Efficiency?
Public Policy How Can Healthcare Optimize IT Spending Efficiency?

In the complex and ever-evolving landscape of healthcare, effectively managing IT spending is crucial. Healthcare providers increasingly rely on technological innovations to meet regulatory requirements, enhance patient care, and improve operational efficiency. Thus, optimizing IT spending is vital

Can We Bridge Rising Drug Costs and Medicaid Challenges?
Business Can We Bridge Rising Drug Costs and Medicaid Challenges?

The KFF Health News article highlights pressing healthcare concerns, notably drug pricing, Medicaid vulnerability, and water fluoridation. The escalating cost of drugs presents a formidable financial barrier to consumers, raising calls for regulatory measures to ensure affordability and access.

Are Politics Sabotaging Women's Health Innovations?
Business Are Politics Sabotaging Women's Health Innovations?

In recent years, the women's health sector has gained attention due to the rise in venture capital investments and emerging scientific research targeting conditions traditionally overlooked by the medical community. Investments in women's health startups have seen a remarkable surge,

Can California Balance Budget Amid Immigrant Health Cuts?
Business Can California Balance Budget Amid Immigrant Health Cuts?

Faisal Zain is a trailblazer in the field of healthcare technology, known for his insightful perspectives on medical device innovation and policy. Today, he shares his expertise in the complex landscape of healthcare policies impacting immigrants, a topical issue in light of California's

HIPAA: Protecting Privacy and Data in Digital Healthcare
Data and Information HIPAA: Protecting Privacy and Data in Digital Healthcare

In today's fast-evolving digital healthcare landscape, safeguarding patient privacy and data is becoming increasingly pivotal. As healthcare services embrace telemedicine and artificial intelligence (AI) capabilities, the Health Insurance Portability and Accountability Act (HIPAA) plays an

Will Prasad's CBER Role Reshape Biopharmaceutical Standards?
Public Policy Will Prasad's CBER Role Reshape Biopharmaceutical Standards?

Vinay Prasad's appointment as head of the FDA's Center for Biologics Evaluation and Research (CBER) attracts attention due to his renowned critical views on premature medical interventions in U.S. healthcare. Known for questioning the reliance on drugs without substantial evidence of

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later